Amy Davies Clinical Oncology Society of Australia Annual Scientific Meeting 2019

Abstracts this author is presenting:

• Implementation of an immune-related adverse events (irAE) education program for healthcare professionals at an Australian multisite tertiary health service. — Poster Session 2
• ⁶⁸Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer after definitive treatment: an Australian prospective study. — Poster Session 1